A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Transcranial magnetic stimulation (TMS) typically requires daily clinic visits over six to eight weeks, a rather rigorous ...

Stimulating two brain areas, nudging them to collectively fire in the same way, increases a person's ability to behave altruistically, according to a study published in the PLOS Biology by Jie Hu from ...

Novel study by researchers at the Rambam Health Care Campus could help 21 million people worldwide suffering from the severe ...

From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

Explore the study on treatment-resistant depression that reveals high-intensity brain stimulation can swiftly reduce symptoms ...

Neuroscientist Soha Farboud of the Donders Institute at Radboud University has succeeded in adjusting activity in specific ...

Through Nexalin America, the Company’s division dedicated to U.S. government engagement, the Company participated in advocacy efforts supporting the inclusion of language favorable to deep brain ...

Non-invasive brain stimulation (NIBS) technologies are rapidly gaining prominence as effective tools for both investigating and modulating brain activity. As these technologies advance and evolve, ...

Chinese company Gestala develops non-invasive ultrasound brain-computer interfaces as alternative to surgical implants, ...